Health
Existing drug masitinib identified as potential inhibitor of SARS-CoV-2 – News-Medical.Net
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COV…
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
The drug, which is called masitinib, potently inhibited the main viral protease 3CLpro that SARs-CoV-2 relies on for infection to proceed once the viral genome has entered the host cell cytoplasm.
The study showed that masitinib di…
-
Noosa News17 hours agoStreet in Italy named after Tassie farmer for kindness shown to Italian POW
-
General21 hours agoBuoyant Albanese plots next phase of Labor dynasty
-
Noosa News18 hours agoWhen ‘Wednesday’ Island Pops Up in Australia, So Will Jenna Ortega, Emma Myers and Tim Burton
-
Business10 hours agoBuy alert! 2 ASX 200 blue-chip shares worth a look now: expert